
The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.
Tetsuya Moritake is associate director of Project Leadership & Operations, Pharmaceutical Sciences at Takeda Pharmaceutical.
The increased use of single-use bags in biologic manufacturing poses the risk of pinholes and other defects that cannot currently be tested for.
Published: September 2nd 2020 | Updated: